← 返回前沿论文

B 淋巴细胞和三级淋巴结构对阴茎鳞状细胞癌具有预后影响

英文原题:B lymphocytes and tertiary lymphoid structures have a prognostic impact on penile squamous cell carcinoma.

PubMed 2025/11/01(内容时间) J Pathol Clin Res Q1 · IF 4.1(JCR 2025)

研究概要

TLSs内高数量的肿瘤浸润B细胞是pSCC的一个有利预后标志物。

中文摘要

几种预后标志物,包括最近在阴茎鳞状细胞癌(pSCC)中发现的TIL(肿瘤浸润淋巴细胞),主要集中于T细胞。B细胞和三级淋巴结构(TLSs)的预后作用尚未得到充分描述。我们对全组织切片进行了TLSs的组织病理学检查,并对CD20和CD138进行了免疫组化检查。B细胞免疫评分(B-IS)根据这两种B细胞/浆细胞标志物(分别为CD20和CD138)的表达将队列分为五个类别。TLSs较少的患者总生存期(OS)较差[风险比(HR)= 2.17;95% CI:0.94-5;p = 0.069]。TLS直径较大与淋巴细胞浸润的存在之间存在显著关联[比值比(OR)= 2.2442;95% CI:1.1022-4.55;p = 0.0208]。低B-IS(HR = 1.89,95% CI:1.18-3.03,p = 0.008)、肿瘤中心CD20 + 细胞数量低(HR = 1.67,95% CI:1.04-2.7,p = 0.035)以及肿瘤浸润前沿CD20 + 细胞数量低(HR = 1.69,95% CI:1.06-2.78;p = 0.028)的患者OS显著较差。高B-IS与免疫组化检测到的突变型p53谱强相关(OR = 4.76,95% CI:1.32-25,p = 0.011)、低T细胞免疫评分(OR = 0.49;95% CI:0.23-1.03;p = 0.051)以及活跃的淋巴细胞浸润(OR = 2.0417,95% CI:1.01-4.76;p = 0.037)。浸润前沿CD20 + 细胞计数高与组织学3级疾病相关(OR = 2.44,95% CI 1.15-5.26,p = 0.015)。还观察到低B-IS与KMT2D(OR 0.31,95% CI:0.07-1.21,p = 0.057)和EGFR(OR = ∞,95% CI:0.86-∞,p = 0.053)突变之间存在关联。总之,TLS内高数量的肿瘤浸润B细胞是pSCC的一个有利预后标志物。这些发现强调需要在病理评估中识别新的微观预后标志物,以指导早期和适当的治疗策略。

展开英文摘要原文

Several prognostic markers, including tumor-infiltrating lymphocytes, which have been recently identified in penile squamous cell carcinoma (pSCC), have focused mostly on T cells. The prognostic role of B cells and tertiary lymphoid structures (TLSs) has not yet been sufficiently described. We examined whole tissue sections histopathologically for TLSs and immunohistochemically for CD20 and CD138. The B-cell immunoscore (B-IS) divided the cohort into five categories based on the expression of these two B-cell/plasma cell markers (CD20 and CD138, respectively). Patients with fewer TLSs had worse overall survival (OS) [hazard ratio (HR) = 2.17; 95% CI: 0.94-5; p = 0.069]. A significant association was identified between a high TLS diameter and the presence of a lymphocytic infiltrate [odds ratio (OR) = 2.2442; 95% CI: 1.1022-4.55; p = 0.0208]. Patients with low B-IS (HR = 1.89, 95% CI: 1.18-3.03, p = 0.008), a low number of CD20 + cells in the tumor center (HR = 1.67, 95% CI: 1.04-2.7, p = 0.035), and a low number of CD20 + cells at the tumor invasion front (HR = 1.69, 95% CI: 1.06-2.78; p = 0.028) had significantly worse OS. High B-ISs were strongly associated with a mutated p53 profile detected by immunohistochemistry (OR = 4.76, 95% CI: 1.32-25, p = 0.011), low T-cell immunoscores (OR = 0.49; 95% CI: 0.23-1.03; p = 0.051), and brisk lymphocytic infiltration (OR = 2.0417, 95% CI: 1.01-4.76; p = 0.037). High CD20 + cell counts at the invasion front were associated with histological grade 3 disease (OR = 2.44, 95% CI 1.15-5.26, p = 0.015). An association was also observed between low B-IS and mutations in KMT2D (OR 0.31, 95% CI: 0.07-1.21, p = 0.057) and EGFR (OR = ∞, 95% CI: 0.86-∞, p = 0.053). In conclusion, high numbers of tumor-infiltrating B cells within TLSs represent a favorable prognostic marker in pSCC. These findings emphasize the need to identify novel microscopic prognostic markers during pathological assessment to guide early and appropriate therapeutic strategies.

论文信息

作者
Zavillová N、Waldauf P、Kendall Bártů M、Čapka D、Hojný J、Prouzová Z、Matěj R、Zachoval R
第一作者单位
Department of Urology, 3rd Faculty of Medicine of Charles University, Thomayer University Hospital, Prague, Czech Republic.Czechia
通讯作者单位
Department of Pathology, 3rd Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic.Czechia
文献类型
非美国政府资助研究
期刊
The journal of pathology. Clinical research2025 Nov
原文标识
PubMed 41235705 · DOI 10.1002/2056-4538.70059